APA (7th ed.) Citation

NK, B., & B, B. (1997). Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. Antimicrobial agents and chemotherapy, 41(11), 2484. https://doi.org/10.1128/AAC.41.11.2484

Chicago Style (17th ed.) Citation

NK, Back, and Berkhout B. "Limiting Deoxynucleoside Triphosphate Concentrations Emphasize the Processivity Defect of Lamivudine-resistant Variants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase." Antimicrobial Agents and Chemotherapy 41, no. 11 (1997): 2484. https://doi.org/10.1128/AAC.41.11.2484.

MLA (9th ed.) Citation

NK, Back, and Berkhout B. "Limiting Deoxynucleoside Triphosphate Concentrations Emphasize the Processivity Defect of Lamivudine-resistant Variants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase." Antimicrobial Agents and Chemotherapy, vol. 41, no. 11, 1997, p. 2484, https://doi.org/10.1128/AAC.41.11.2484.